The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Impact of disease progression (DP) date determination method on post progression survival (PPS) and DP metrics in advanced lung cancer.
Sumithra J. Mandrekar
No relevant relationships to disclose
Nathan R. Foster
No relevant relationships to disclose
Yingwei Qi
No relevant relationships to disclose
Grace K. Dy
No relevant relationships to disclose
Aminah Jatoi
No relevant relationships to disclose
Julian R. Molina
No relevant relationships to disclose
James R. Jett
No relevant relationships to disclose
Philip J. Stella
No relevant relationships to disclose
Steven E. Schild
No relevant relationships to disclose
Alex A. Adjei
No relevant relationships to disclose